학술논문
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82)
Document Type
Article
Author
Vienot, A.; Jacquin, M.; Rebucci-Peixoto, M.; Pureur, D.; Stouvenot, M.; Adotevi, O.; Meurisse, A.; Vernerey, D.; Borg, C.; Di Martino, V.; Ghiringhelli, F.; Assenat, E.; Hammel, P.; Rosmorduc, O.; Allaire, M.; Bouattour, M.; Regnault, H.; Fratte, S.; Raymond, E.; Soularue, E.; Husson-Wetzel, S.; Muller, A.; Clairet, A.-L.; Fagnoni-Legat, C.
Source
In: BMC Cancer . (BMC Cancer, December 2023, 23(1))
Subject
Language
English
ISSN
14712407